1371608-50-2

Upstream product

• 796600-15-2 2-chloro-4-fluoro-3-methylbenzonitrile 
• 1182366-63-7 (2R,3S)-2-(3-chloro-4-cyano-2-methylphenylamino)-3-hydroxybutanoic acid 
• 1371609-13-0 (2R,3S)-methyl-2-(3-chloro-4-cyano-2-methylphenylamino)-3-hydroxybutanoate 
• 1371609-14-1 (4R,5S)-methyl 3-(3-chloro-4-cyano-2-methylphenyl)-5-methyl-2-oxooxazolidine-4-carboxylate 
• 1371609-15-2 2-chloro-4-((4S,5S)-4-(hydroxymethyl)-5-methyl-2-oxooxazolidin-3-yl)-3-methylbenzonitrile 
• 1371609-16-3 C₁₃H₁₁ClN₂O₃ 

Relevant academic research and scientific papers

SELECTIVE ANDROGEN RECEPTOR MODULATORS

This invention provides compounds of formula I, pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor, methods of treating diseases beneficially treated by an androgen receptor modulator (e.g., sarcopenia, prostate cancer, contraception, type 2 diabetes related disorders or diseases, anemia, depression, and renal disease) and processes for making compounds and intermediates useful in the preparation of same.